GlassScriptPhysician profile
Michelle Park
NPI 1811428667
$2,440.41
in general payments reported to CMS, 2019-2025
13 companies · $2,127 in 2025
The $2,127 reported for 2025 was more than what 97% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
See the full distribution for Hospice and Palliative Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.55 · 2024: $283 · 2025: $2,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,286 · Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,285.61 |
| Food and Beverage | $1,154.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,022.11 | 2025 | Synchromedii |
| Astrazeneca Pharmaceuticals LP | $122.03 | 2023-2024 | Wainua, Farxiga |
| Scpharmaceuticals INC. | $44.92 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $41.91 | 2024-2025 | Winrevair, Verquvo |
| Cvrx, INC. | $30.50 | 2025 | Barostim Neo System |
| Amgen INC. | $28.43 | 2024 | Repatha |
| Lantheus Medical Imaging, INC. | $27.97 | 2024 | |
| Abbott Laboratories | $25.91 | 2024 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.52 | 2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $23.58 | 2024 | Amvuttra |
| Collegium Pharmaceutical, INC. | $19.00 | 2024 | Xtampza |
| Lexicon Pharmaceuticals, INC. | $14.96 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.57 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.